article thumbnail

Medical Documentation

RX Note

Since we don't even remember what we eat this morning, it is vital to make proper medical documentation. The amendments should be documented on the prescription and endorsed with “prescriber contacted” (PC), dated and initialled by the pharmacist/person dispensing.

article thumbnail

Another IRA Surprise: Part B Coinsurance Inflation Adjustments Are Increasing Patient Costs

Drug Channels

As we document below, a growing share of Part B drugs have inflation-adjusted coinsurance rates that have been increasing , not declining. Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. Chalk off these coinsurance surprises to yet another unintended consequence of the IRA.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

How to Run DMC? It’s Tricky – FDA’s New Draft Guidance Provides Updated Recommendations on How to Best Use Data Monitoring Committees in Clinical Trials

FDA Law Blog: Biosimilars

Clissold — The trio of CDER, CBER, and CDRH released a new draft guidance titled “ Use of Data Monitoring Committees in Clinical Trials ” that revises the 2006 guidance “Establishment and Operation of Clinical Trial Data Monitoring Committees” and, when final, will replace the 2006 guidance. Increased Connections Between a DMC and FDA?

article thumbnail

Follow the 340B Prescription Dollar: How PBMs Profit from 340B Contract Pharmacies (Video)

Drug Channels

I then document how five multi-billion-dollar, for-profit, publicly traded pharmacy chains and pharmacy benefit managers (PBMs)—Cigna (via Express Scripts), CVS Health, UnitedHealth Group (via OptumRx), and Walgreens, Walmart—continue to dominate the 340B contract pharmacy market. Click here if you can’t see the video below.

article thumbnail

PBMs and Drug Spending in 2020: Data from CVS Health (sort of), Express Scripts, Navitus, and WellDyne (rerun)

Drug Channels

I document this disappointing state of affairs below. Read more » Copyright © 2006-2021 Pembroke Consulting, Inc. CVS Health has published only a bare bones summary, while Prime Therapeutics, MedImpact, and other large PBMs have stopped publishing trend reports. Read on as I spread all the the k-poppin' details.

article thumbnail

Medicare Part D in 2024: Mapping Large Chains' Position in 2024’s Preferred Pharmacy Networks

Drug Channels

In Medicare Part D in 2024: The Seven Largest Companies' Preferred Pharmacy Networks and the Coming Collapse of the PDP Market , I documented how those networks now dominate stand-alone Medicare Part D prescription drug plans (PDPs) and have become a major presence in Medicare Advantage prescription drug (MA-PD) plans. to 1:30 p.m.

article thumbnail

Drug Channels Recommends: “Uncontrolled Spread” by Scott Gottlieb

Drug Channels

Dr. Gottlieb documents—with great specificity—how and why our government’s public health infrastructure failed us during the pandemic. Read more » Copyright © 2006-2021 Pembroke Consulting, Inc. I suggest Uncontrolled Spread: Why COVID-19 Crushed Us and How We Can Defeat the Next Pandemic , by Scott Gottlieb, M.D. Amazon link).